Radomski, M., Zeh, H.J., Edington, H.D., Pingpank, J.F., Butterfield, L.H., Whiteside, T.L., Wieckowski, E., Bartlett, D.L., & Kalinski, P. (2016). Prolonged intralymphatic delivery of dendritic cells through implantable lymphatic ports in patients with advanced cancer. J Immunother Cancer, 4(1), 24.BMJ. doi: 10.1186/s40425-016-0128-y.
Downs-Canner, S., Ravindranathan, R., Edwards, R.P., Kalinski, P., Odunsi, K., Bartlett, D.L., & Obermajer, N. (2015). Ex-Th17 Foxp3+ T cells - a novel subset of Foxp3+ T cells induced in cancer. Journal for ImmunoTherapy of Cancer, 3(Suppl 2), p273.BMJ. doi: 10.1186/2051-1426-3-s2-p273.
Hansen, M., Wieckowski, E., Svane, I.M., Edwards, R.P., & Kalinski, P. (2015). Selective costimulation by IL-15R/IL-15, but not IL-2R/IL-2, allows the induction of high numbers of tumor-specific CD8+ T cells by human dendritic cells matured in conditions of acute inflammation. Journal for ImmunoTherapy of Cancer, 3(Suppl 2), p223.BMJ. doi: 10.1186/2051-1426-3-s2-p223.
Muthuswamy, R., Wang, L., Pitteroff, J., Gingrich, J.R., & Kalinski, P. (2015). Combination of IFNα and poly-I:C reprograms bladder cancer microenvironment for enhanced CTL attraction. J Immunother Cancer, 3(1), 6.BMJ. doi: 10.1186/s40425-015-0050-8.
Sinadinos, A., Young, C.N.J., Al-Khalidi, R., Teti, A., Kalinski, P., Mohamad, S., Floriot, L., Henry, T., Tozzi, G., Jiang, T., Wurtz, O., Lefebvre, A., Shugay, M., Tong, J., Vaudry, D., Arkle, S., doRego, J.C., & Górecki, D.C. (2015). P2RX7 purinoceptor: a therapeutic target for ameliorating the symptoms of duchenne muscular dystrophy. In Peltz, G. (Ed.). PLoS Med, 12(10), e1001888.Public Library of Science (PLoS). doi: 10.1371/journal.pmed.1001888.
Muthuswamy, R., Jenkins, F., Bovbjerg, D., & Kalinski, P. (2013). Synergistic induction of cancer-related immunosuppression by β2-adrenergic stress mediators and P38MAPK inflammatory pathway. Journal for ImmunoTherapy of Cancer, 1(Suppl 1), p191.BMJ. doi: 10.1186/2051-1426-1-s1-p191.
Obermajer, N., Wong, J.L., Edwards, R.P., Chen, K., Scott, M., Khader, S., Kolls, J.K., Odunsi, K., Billiar, T.R., & Kalinski, P. (2013). Development and stability of Th17 cells in ovarian cancer requires nitric oxide and endogenous NOS2 activity in cancer-associated CD4+ T cells. Journal for ImmunoTherapy of Cancer, 1(Suppl 1), p146.BMJ. doi: 10.1186/2051-1426-1-s1-p146.
Stroncek, D.F., Melief, C.J., Castiello, L., Cesano, A., Cheever, M.A., Civini, S., Comin-Anduix, B., Gajewski, T.F., Greenberg, P.D., Kalinski, P., Kaufman, H.L., Kershaw, M.H., Khleif, S.N., Marincola, F., Merritt, W., Munn, D.H., Powell, D.J., Restifo, N.P., Rosenberg, S.A., Puri, R.K., Streicher, H., Szalay, A.A., Yee, C., Zitvogel, L., & Ribas, A. (2013). Highlights of the society for immunotherapy of cancer (SITC) 27th annual meeting. Journal for ImmunoTherapy of Cancer, 1(1), 4.BMJ. doi: 10.1186/2051-1426-1-4.
Wong, J.L., Muthuswamy, R., Bartlett, D.L., & Kalinski, P. (2013). IL-18-based combinatorial adjuvants promote the NK-DC-mediated production of the CCR7 ligand CCL19 in lymph nodes from cancer patients. Journal for ImmunoTherapy of Cancer, 1(Suppl 1), o21.BMJ. doi: 10.1186/2051-1426-1-s1-o21.
Obermajer, N., & Kalinski, P. (2012). Generation of myeloid-derived suppressor cells using prostaglandin E2. Transplant Res, 1(1), 15.Springer Nature. doi: 10.1186/2047-1440-1-15.
Balwit, J.M., Kalinski, P., Sondak, V.K., Coulie, P.G., Jaffee, E.M., Gajewski, T.F., & Marincola, F.M. (2011). Review of the 25th annual scientific meeting of the International Society for Biological Therapy of Cancer. J Transl Med, 9(1), 60.Springer Nature. doi: 10.1186/1479-5876-9-60.
Fox, B.A., Schendel, D.J., Butterfield, L.H., Aamdal, S., Allison, J.P., Ascierto, P.A., Atkins, M.B., Bartunkova, J., Bergmann, L., Berinstein, N., Bonorino, C.C., Borden, E., Bramson, J.L., Britten, C.M., Cao, X., Carson, W.E., Chang, A.E., Characiejus, D., Choudhury, A.R., Coukos, G., de Gruijl, T., Dillman, R.O., Dolstra, H., Dranoff, G., Durrant, L.G., Finke, J.H., Galon, J., Gollob, J.A., Gouttefangeas, C., Grizzi, F., Guida, M., Håkansson, L., Hege, K., Herberman, R.B., Hodi, F.S., Hoos, A., Huber, C., Hwu, P., Imai, K., Jaffee, E.M., Janetzki, S., June, C.H., Kalinski, P., Kaufman, H.L., Kawakami, K., Kawakami, Y., Keilholtz, U., Khleif, S.N., Kiessling, R., Kotlan, B., Kroemer, G., Lapointe, R., Levitsky, H.I., Lotze, M.T., Maccalli, C., Maio, M., Marschner, J.P., Mastrangelo, M.J., Masucci, G., Melero, I., Melief, C., Murphy, W.J., Nelson, B., Nicolini, A., Nishimura, M.I., Odunsi, K., Ohashi, P.S., O'Donnell-Tormey, J., Old, L.J., Ottensmeier, C., Papamichail, M., Parmiani, G., Pawelec, G., Proietti, E., Qin, S., Rees, R., Ribas, A., Ridolfi, R., Ritter, G., Rivoltini, L., Romero, P.J., Salem, M.L., Scheper, R.J., Seliger, B., Sharma, P., Shiku, H., Singh-Jasuja, H., Song, W., Straten, P.T., Tahara, H., Tian, Z., van Der Burg, S.H., von Hoegen, P., Wang, E., Welters, M.J., Winter, H., Withington, T., Wolchok, J.D., Xiao, W., Zitvogel, L., Zwierzina, H., Marincola, F.M., Gajewski, T.F., Wigginton, J.M., & Disis, M.L. (2011). Defining the critical hurdles in cancer immunotherapy. J Transl Med, 9(1), 214.Springer Nature. doi: 10.1186/1479-5876-9-214.
John, E., Laskow, T.C., Buchser, W.J., Pitt, B.R., Basse, P.H., Butterfield, L.H., Kalinski, P., & Lotze, M.T. (2010). Zinc in innate and adaptive tumor immunity. J Transl Med, 8(1), 118.Springer Nature. doi: 10.1186/1479-5876-8-118.
Wong, J., Obermajer, N., Edwards, R., Bartlett, D., & Kalinski, P. (2014). Activation of the COX2/PGE2 axis by immune effector cells promotes the self-limiting nature of type-1 immunity in cancer tissues. In JOURNAL OF IMMUNOLOGY, 192(Suppl 3), (p. p239).BMJ. doi: 10.1186/2051-1426-2-s3-p239.